Rucaparib for maintenance treatment of advanced ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy

  • Technology appraisal guidance
  • TA1055
  • Published: 

Evidence

Documents containing the evidence that was used to develop the recommendations.

Supporting evidence